| Authors: |
Wang HY; Department of Pediatrics, Weill Cornell Medicine, New York, NY, 10065, USA.; Duke University Medical Center, Duke Human Vaccine Institute, Durham, NC, 27710, USA., Li L; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.; Takeda Pharmaceutical, San Diego, CA, 92121, USA., Nelson CS; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Barfield R; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, 27710, USA.; Center for Human Systems Immunology, Duke University Medical Center, Durham, NC, 27710, USA., Valencia S; Duke University Medical Center, Duke Human Vaccine Institute, Durham, NC, 27710, USA., Chan C; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, 27710, USA.; Center for Human Systems Immunology, Duke University Medical Center, Durham, NC, 27710, USA., Muramatsu H; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Lin PJC; Acuitas Therapeutics, Vancouver, BC, V6T 1Z3, Canada., Pardi N; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., An Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Weissman D; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Permar SR; Department of Pediatrics, Weill Cornell Medicine, New York, NY, 10065, USA. sallie.permar@med.cornell.edu. |
